Human MAIT cell response profiles biased toward IL-17 or IL-10 are distinct effector states directed by the cytokine milieuShow others and affiliations
2025 (English)In: Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, E-ISSN 1091-6490, Vol. 122, no 6, article id e2414230122Article in journal (Refereed) Published
Abstract [en]
Mucosal-associated invariant T (MAIT) cells are unconventional T cells that mediate rapid antimicrobial immune responses to antigens derived from microbial riboflavin pathway metabolites presented by the evolutionarily conserved MR1 molecules. MAIT cells represent a large pre-expanded T cell subset in humans and are involved in both protective immunity and inflammatory immunopathology. However, what controls the functional heterogeneity of human MAIT cell responses is still largely unclear. Here, combining functional and transcriptomic analyses, we investigate how MAIT cell response programs are influenced by the cytokine milieu at the time of antigen recognition. Activation by MR1-presented antigen together with IL-12 induces intermediate levels of IFNγ and TNF, as well as a regulatory profile with substantial IL-10 production and elevated expression of TIM-3, LAG-3, and PD-1. Activation by the combination of antigen and IL-12 induces a c-MAF-dependent program required for IL-10 production. The MAIT cell-derived IL-10 mediates both autocrine and paracrine immune regulation. In contrast, coactivation of MAIT cells with IL-18 induces IL-17, GM-CSF, IFNγ, and TNF, without IL-10. Notably, IL-18 dominantly counteracts IL-10 expression. The activation states biased toward IL-10 or IL-17 production are reversible and do not represent stable subsets. Finally, MR1-restricted TCR-mediated activation without cytokine coactivation drives primarily granzyme B cytolytic arming. Altogether, these findings demonstrate that human MAIT cells adapt their functional effector response during antigen recognition to cytokine cues in the microenvironment, and identify programs biased toward either regulatory c-MAF-dependent IL-10 expression, or an inflammatory IL-17 and GM-CSF profile.
Place, publisher, year, edition, pages
Proceedings of the National Academy of Sciences (PNAS), 2025. Vol. 122, no 6, article id e2414230122
Keywords [en]
IL-10, MAIT cells, MR1, T cells, human
National Category
Immunology in the medical area
Identifiers
URN: urn:nbn:se:oru:diva-119115DOI: 10.1073/pnas.2414230122ISI: 001459599300013PubMedID: 39903121Scopus ID: 2-s2.0-85218035406OAI: oai:DiVA.org:oru-119115DiVA, id: diva2:1935291
Funder
Swedish Research Council, 2020-01743Swedish Research Council, 2023-02857Swedish Cancer Society, 20-1142PjFSwedish Cancer Society, 23-2912PjSwedish Heart Lung Foundation, 2021044722Swedish Heart Lung Foundation, 20230551Karolinska Institute
Note
Funding:
This research was supported by grants to J.K.S. from the Swedish Research Council (2020-01743, 2023-02857), the Swedish Cancer Society (20-1142PjF, 23-2912Pj), the Swedish Heart-Lung Foundation (2021044722, 20230551), the Center for Innovative Medicine (FoUI-989096) and Karolinska Institutet. T.R.M. was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – 496946670. D.P.F. and J.Y.W.M. were supported by Australian National Health and Medical Research Council Leadership Investigator (2009551), Australian Research Council (CE200100012), and US NIH R01 (AI148407) grants.
2025-02-062025-02-062025-04-15Bibliographically approved